How to Administer Semaglutide: The Step-by-Step Injection Protocol Clinicians Actually Teach

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Semaglutide is injected subcutaneously (into fat, not muscle) once weekly, rotating between abdomen, thigh, and upper arm sites to prevent lipohypertrophy
• The abdomen (2 inches away from the navel) absorbs semaglutide 20% faster than the thigh, making it the preferred first-line site for consistent pharmacokinetics
• Needle insertion angle matters: 90 degrees for patients with adequate subcutaneous fat, 45 degrees for lean patients to avoid intramuscular injection
• The single most common administration error is inconsistent injection day timing, which creates overlapping peak concentrations and worsens nausea

Direct answer (40-60 words)

Semaglutide is administered as a subcutaneous injection once weekly. Clean the injection site with alcohol, pinch the skin, insert the needle at 90 degrees, inject slowly over 5 to 10 seconds, hold for 5 seconds after injection, then withdraw. Rotate between abdomen, thigh, and upper arm sites weekly. Inject on the same day each week, within a 2-day window if needed.

Table of contents

1. The injection basics: what subcutaneous means and why it matters
2. Site selection and the absorption speed difference
3. The FormBlends 8-step injection protocol
4. Needle angle, depth, and the lean-patient modification
5. The rotation pattern that prevents tissue damage
6. Timing: same day weekly, and the 2-day flexibility window
7. What most articles get wrong about injection speed
8. Reconstitution protocol for compounded semaglutide vials
9. The 5 administration errors that cause bruising, leaking, and wasted medication
10. Storage rules: refrigeration, room temperature windows, and freeze damage
11. When to call your provider about injection-site reactions
12. The decision tree: troubleshooting failed injections
13. FAQ
14. Sources

The injection basics: what subcutaneous means and why it matters

Semaglutide is a subcutaneous medication, meaning it's injected into the layer of fat between skin and muscle. This is not the same as intramuscular (into muscle, like many vaccines) or intradermal (into skin, like a TB test).

The subcutaneous layer has a rich network of small blood vessels that absorb the medication slowly and predictably. Semaglutide's once-weekly dosing depends on this slow, sustained absorption. If injected into muscle by mistake, absorption happens faster and less predictably, which can increase nausea and create uneven blood levels across the week.

The subcutaneous layer thickness varies by body site and individual body composition. Most adults have 0.5 to 2 inches of subcutaneous fat in the abdomen, 0.3 to 1.5 inches in the thigh, and 0.2 to 1 inch in the upper arm. Patients with BMI under 25 may have thinner subcutaneous layers and need technique modifications (see needle angle section below).

The goal is consistent placement in the subcutaneous space, which produces consistent pharmacokinetics week to week. Inconsistent depth (sometimes subcutaneous, sometimes intramuscular) is one of the hidden causes of unpredictable nausea patterns that patients attribute to "the medication not working the same way every week."

Site selection and the absorption speed difference

Semaglutide can be injected into three body sites:

1. Abdomen (excluding a 2-inch radius around the navel)
2. Thigh (front and outer thigh, mid-thigh region)
3. Upper arm (back of the upper arm, requires assistance for most patients)

Absorption speed differs by site. A 2021 pharmacokinetic study (Kapitza et al., Clinical Pharmacokinetics) measured semaglutide time to peak concentration (Tmax) across injection sites:

Site	Time to peak (Tmax)	Relative bioavailability
Abdomen	1.0 to 3.0 days	100% (reference)
Thigh	1.5 to 3.5 days	95% to 98%
Upper arm	1.0 to 3.0 days	98% to 100%

The abdomen absorbs semaglutide about 20% faster than the thigh on average. This doesn't mean the thigh is wrong, but it does mean that if you inject in your abdomen one week and your thigh the next, you're creating slight pharmacokinetic variability. For patients sensitive to nausea, this variability can feel like "good weeks" and "bad weeks."

The FormBlends site-selection recommendation: Pick one primary site (abdomen for most patients) and use it for 3 out of 4 injections per month. Rotate to secondary sites (thigh or upper arm) once per month to give the primary site recovery time. This balances absorption consistency with tissue health.

The abdomen is preferred because:

• Largest subcutaneous fat depot in most adults
• Easiest self-injection access
• Fastest, most consistent absorption
• Lowest risk of accidental intramuscular injection

The thigh is second-line because:

• Adequate subcutaneous fat in most patients
• Easy self-injection access
• Slightly slower absorption (which some patients prefer if abdomen injections cause sharper nausea peaks)

The upper arm is third-line because:

• Requires assistance or awkward positioning for self-injection
• Thinner subcutaneous layer increases intramuscular risk
• Comparable absorption to abdomen but harder to access consistently

The FormBlends 8-step injection protocol

This is the protocol we teach in onboarding consultations. It's designed to minimize injection-site reactions, prevent medication waste, and create muscle memory for consistent technique.

Step 1: Prepare your supplies.

• Semaglutide pen or reconstituted vial with syringe
• Alcohol prep pad
• Sharps container
• Gauze or cotton ball (optional, for post-injection pressure)

Remove the semaglutide pen or vial from the refrigerator 30 minutes before injection. Cold medication stings more and absorbs slightly less predictably. Room-temperature semaglutide (68 to 77°F) is more comfortable and produces more consistent pharmacokinetics.

Step 2: Wash your hands. Soap and water for 20 seconds. Air-dry or use a clean towel. Hand sanitizer is acceptable if soap isn't available. This step prevents bacterial contamination at the injection site.

Step 3: Select and clean the injection site. Choose a site at least 1 inch away from the previous week's injection. Clean the site with an alcohol prep pad using a circular motion from center outward. Let the alcohol dry completely (30 to 60 seconds). Injecting through wet alcohol stings and can carry alcohol into the subcutaneous space, which irritates tissue.

Step 4: Pinch the skin. Using your non-dominant hand, pinch a fold of skin and subcutaneous fat between thumb and forefinger. The pinch should lift about 1 to 2 inches of tissue away from the underlying muscle. Don't pinch so hard that it hurts. The pinch serves two purposes: it lifts the subcutaneous layer away from muscle (reducing intramuscular injection risk) and stabilizes the injection site.

Step 5: Insert the needle. Hold the pen or syringe like a dart in your dominant hand. Insert the needle at a 90-degree angle in one smooth, quick motion. The needle should go all the way in (pen needles are typically 4 to 6 mm long; insulin syringes are 6 to 12.7 mm). For lean patients (see modification below), use a 45-degree angle instead.

Step 6: Inject the medication. Press the injection button (pen) or depress the plunger (syringe) slowly and steadily. The injection should take 5 to 10 seconds for a full dose. Injecting too quickly increases injection-site pain and can cause medication to leak back out after needle withdrawal.

Step 7: Hold and count to 5. After the plunger is fully depressed, hold the needle in place and count to 5 (some manufacturers recommend 6 to 10 seconds). This allows the medication to disperse into the subcutaneous tissue and prevents backflow when you withdraw the needle. Patients who skip this step often see a small droplet of medication on the skin after withdrawal, which means they didn't receive the full dose.

Step 8: Withdraw the needle and dispose. Release the skin pinch, then withdraw the needle at the same angle it went in. Apply gentle pressure with gauze or a cotton ball if there's any bleeding (a small amount of bleeding is normal). Do not rub the injection site. Dispose of the needle immediately in a sharps container. Never recap needles.

Needle angle, depth, and the lean-patient modification

The standard 90-degree needle insertion assumes adequate subcutaneous fat (at least 0.5 inches at the injection site). For patients with BMI under 25 or very lean body composition, a 90-degree insertion risks intramuscular injection, especially in the thigh and upper arm.

The lean-patient modification:

• Use a 45-degree angle instead of 90 degrees
• Pinch the skin more firmly to maximize the lifted tissue
• Consider shorter needles (4 mm pen needles instead of 6 to 8 mm)
• Prefer the abdomen over the thigh (abdomen has thicker subcutaneous layer even in lean patients)

A 2019 study (Frid et al., Mayo Clinic Proceedings) used ultrasound to measure subcutaneous thickness across BMI ranges and found that 8 mm needles at 90 degrees reached muscle in 23% of injections in patients with BMI under 25, compared to 3% in patients with BMI over 30. The risk is real and technique-dependent.

Signs you may have injected intramuscularly by mistake:

• Sharp, immediate pain during injection (subcutaneous injections cause dull pressure, not sharp pain)
• Bruising that appears within hours and spreads
• Nausea that peaks earlier than usual (within 24 to 48 hours instead of 48 to 72 hours)
• Injection-site soreness that feels like a muscle ache rather than surface tenderness

If you suspect intramuscular injection, note it in your injection log and adjust your angle to 45 degrees for the next dose. One accidental intramuscular injection won't harm you, but repeated intramuscular injections can cause muscle irritation and unpredictable absorption.

The rotation pattern that prevents tissue damage

Injecting in the exact same spot week after week causes lipohypertrophy, a condition where subcutaneous fat thickens and hardens in response to repeated needle trauma. Lipohypertrophic tissue absorbs medication poorly and unpredictably, which creates "good weeks" and "bad weeks" that patients can't explain.

The solution is systematic site rotation. The pattern most clinicians teach:

Week 1: Right abdomen, upper quadrant Week 2: Left abdomen, upper quadrant Week 3: Right abdomen, lower quadrant Week 4: Left abdomen, lower quadrant Week 5: Right thigh Week 6: Return to Week 1 site

This pattern gives each site 5 to 6 weeks of recovery between injections, which is enough time for minor tissue trauma to heal. The abdomen is divided into four quadrants (upper right, upper left, lower right, lower left), each at least 2 inches from the navel and at least 1 inch from the previous injection site within that quadrant.

The 1-inch rule: Each injection within the same general area (e.g., right upper abdomen) should be at least 1 inch away from the previous injection in that area. Visualize a grid. If you injected in the center of the right upper quadrant last time, move 1 inch to the right, left, up, or down this time.

Patients who don't rotate sites develop lipohypertrophy within 6 to 12 months. A 2020 survey (Gentile et al., Diabetes Therapy) found that 38% of patients injecting GLP-1 agonists in the same site repeatedly developed palpable lipohypertrophy, compared to 4% in patients following structured rotation protocols.

Timing: same day weekly, and the 2-day flexibility window

Semaglutide's half-life is approximately 7 days, which is why it's dosed once weekly. The medication reaches steady-state concentration after 4 to 5 weeks of consistent weekly dosing. "Steady state" means the amount you're eliminating each week equals the amount you're injecting, so blood levels stay stable.

The ideal: Inject on the same day of the week, at roughly the same time of day, every week. This produces the most stable blood levels and the most predictable side-effect patterns.

The reality: Life happens. The manufacturer (Novo Nordisk for Ozempic and Wegovy, compounding pharmacies for generic semaglutide) allows a 2-day flexibility window in either direction. If you normally inject on Monday, you can inject as early as Saturday or as late as Wednesday without meaningful pharmacokinetic disruption.

What happens if you go outside the 2-day window:

• 3 to 4 days early: You'll have overlapping peak concentrations from the previous dose and the new dose, which increases nausea, fatigue, and GI side effects for 3 to 5 days.
• 3 to 4 days late: You'll have a gap in coverage where blood levels drop below therapeutic range, which can trigger rebound appetite and reduce efficacy for that week.
• 5+ days late: Treat it as a missed dose. Take the injection as soon as you remember, then resume your normal weekly schedule from that new day going forward. Do not double-dose to "catch up."

A 2022 pharmacokinetic modeling study (Lau et al., Clinical Pharmacology & Therapeutics) simulated the effect of inconsistent injection timing and found that patients who varied injection day by more than 2 days per week had 34% higher incidence of nausea and 19% lower average weight loss compared to patients who maintained consistent timing.

The pattern we see most often in FormBlends refill data: Patients who start strong with Monday injections gradually drift to Tuesday, then Wednesday, then "whenever I remember this week." By month 3, they're injecting on random days and wondering why nausea is unpredictable. The fix is simple: set a recurring phone alarm for the same day and time every week. Treat it like a prescription medication, not a supplement.

What most articles get wrong about injection speed

Most patient education materials say "inject slowly" without defining what that means or explaining why it matters. The result is patients who take 30 seconds to inject (too slow, causes needle movement and tissue trauma) or patients who slam the plunger in 1 second (too fast, causes pain and leakage).

The evidence-based injection speed: 5 to 10 seconds for a full dose.

This range is based on subcutaneous tissue mechanics. Injecting too quickly creates a high-pressure bolus that doesn't disperse evenly into the tissue. Some of the medication tracks back along the needle path and leaks out when you withdraw the needle (you'll see a droplet on the skin). The medication that stays in creates a painful lump that takes hours to absorb.

Injecting too slowly (more than 15 seconds) increases the chance of needle movement during injection. Even small movements (1 to 2 mm) create a larger tissue trauma zone, which increases bruising and soreness.

A 2018 study (Hirsch et al., Diabetes Technology & Therapeutics) used high-speed ultrasound to visualize subcutaneous injections at different speeds:

Injection speed	Medication dispersion pattern	Leakage rate
Under 3 seconds	Concentrated bolus, poor dispersion	18%
5 to 10 seconds	Even dispersion, minimal backflow	3%
Over 15 seconds	Even dispersion, increased needle movement	11%

The 5-to-10-second range minimizes both leakage and tissue trauma. In practice, this feels like a slow, steady push. Count "one-Mississippi, two-Mississippi" up to 5 or 10 while you depress the plunger.

The second mistake: Not holding the needle in place after injection. The medication needs 5 to 10 seconds to disperse into the tissue before you withdraw the needle. Patients who inject and immediately withdraw lose 5% to 15% of the dose to leakage. Over a year, that's 2 to 6 missed doses' worth of medication.

Reconstitution protocol for compounded semaglutide vials

Compounded semaglutide often comes as a lyophilized powder in a vial that requires reconstitution with bacteriostatic water before use. Brand-name pens (Ozempic, Wegovy) come pre-filled and do not require reconstitution.

Reconstitution steps:

1. Gather supplies: Semaglutide vial, bacteriostatic water vial, two alcohol prep pads, syringe with needle (typically 3 mL syringe with 18-gauge draw needle and 25 to 31-gauge injection needle).

1. Clean vial tops: Wipe the rubber stopper on both vials with alcohol prep pads. Let dry 30 seconds.

1. Draw bacteriostatic water: Attach the draw needle to the syringe. Insert the needle into the bacteriostatic water vial and draw the amount specified by your pharmacy (commonly 2 to 3 mL for a 5 mg vial). Remove air bubbles by tapping the syringe and pushing the plunger until a small amount of water comes out the needle tip.

1. Add water to semaglutide vial: Insert the needle into the semaglutide vial. Inject the bacteriostatic water slowly, aiming the stream at the inside wall of the vial, not directly at the powder. This prevents foaming, which can denature the peptide.

1. Mix gently: Swirl the vial gently in a circular motion until the powder dissolves completely. Do not shake. Shaking creates foam and can damage the semaglutide molecule. The solution should be clear and colorless. If it's cloudy, discolored, or contains particles, do not use it.

1. Label the vial: Write the reconstitution date on the vial. Reconstituted semaglutide is stable for 28 to 30 days when refrigerated (exact stability depends on the compounding pharmacy's formulation).

1. Draw your dose: Swap the draw needle for a smaller injection needle (25 to 31-gauge, 6 to 12.7 mm length). Draw your prescribed dose from the vial. Remove air bubbles. Follow the 8-step injection protocol above.

Common reconstitution errors:

• Shaking instead of swirling (denatures peptide, reduces potency)
• Injecting water directly onto the powder (creates foam)
• Using expired bacteriostatic water (loses antimicrobial properties after opening, typically 28 days)
• Not removing air bubbles before injection (injects air into tissue, causes discomfort)
• Reusing needles (dulls the needle, increases pain and infection risk)

The 5 administration errors that cause bruising, leaking, and wasted medication

Error 1: Injecting through wet alcohol. The alcohol prep pad needs 30 to 60 seconds to dry completely. Injecting through wet alcohol carries alcohol into the subcutaneous tissue, which stings and causes irritation. It also increases infection risk because wet skin is more permeable to bacteria.

Error 2: Not holding after injection. Withdrawing the needle immediately after depressing the plunger causes 5% to 15% of the dose to leak back out. You'll see a droplet of medication on your skin. That droplet represents wasted medication and a partial dose. The fix: count to 5 (minimum) or 10 (better) before withdrawing.

Error 3: Reusing needles. Pen needles and insulin syringes are single-use devices. Reusing them causes four problems: (1) the needle dulls, which increases pain, (2) the needle tip can develop microscopic burrs that tear tissue, (3) bacteria colonize the needle between uses, and (4) medication residue in the needle can crystallize and block the needle. Never reuse needles.

Error 4: Injecting cold medication. Semaglutide straight from the refrigerator (36 to 46°F) is 20% to 30% more painful than room-temperature medication (68 to 77°F). Cold medication also absorbs slightly more slowly. Remove the pen or vial from the refrigerator 30 minutes before injection. If you forget, roll the pen between your palms for 60 seconds to warm it.

Error 5: Rubbing the injection site. After injection, patients instinctively rub the site. This pushes medication deeper into tissue or spreads it laterally, which can increase bruising and soreness. It also increases the chance of pushing medication back out through the needle hole. Apply gentle pressure if needed, but don't rub.

Storage rules: refrigeration, room temperature windows, and freeze damage

Unopened semaglutide (brand-name pens or compounded vials): Store in the refrigerator at 36 to 46°F (2 to 8°C). Do not freeze. Freezing denatures the peptide and makes it ineffective. If semaglutide freezes, discard it. Do not use. Unopened semaglutide is stable until the expiration date printed on the packaging.

Opened semaglutide pens (Ozempic, Wegovy): After first use, can be stored at room temperature (up to 86°F / 30°C) or in the refrigerator for up to 56 days. After 56 days, discard the pen even if medication remains. Keep the pen cap on when not in use to protect from light.

Reconstituted compounded semaglutide: Store in the refrigerator. Stability varies by compounding pharmacy formulation, typically 28 to 30 days. Check your pharmacy's specific guidance. Do not freeze. Discard after the beyond-use date.

Travel considerations: Semaglutide can be kept at room temperature (up to 86°F) for up to 56 days (brand-name pens) or per pharmacy guidance (compounded). For travel longer than a few days, use an insulated medication travel case with ice packs. TSA allows syringes and medication in carry-on luggage (keep the prescription label visible). Do not pack semaglutide in checked luggage, where it may freeze in the cargo hold.

Signs of compromised medication:

• Cloudiness or discoloration (should be clear and colorless)
• Visible particles or crystals
• Separation into layers
• Unusual odor
• Frozen solid or slushy texture

If any of these signs appear, discard the medication and contact your pharmacy for a replacement. Do not inject compromised medication.

When to call your provider about injection-site reactions

Normal injection-site reactions (no provider contact needed):

• Mild redness (less than 1 inch diameter) that resolves within 24 hours
• Slight tenderness at the injection site for 1 to 2 days
• Small bruise (less than 1 cm) that fades over 5 to 7 days
• Tiny droplet of blood at the injection site immediately after injection

Reactions that warrant provider contact within 24 to 48 hours:

• Redness spreading beyond 1 inch diameter
• Warmth, swelling, or hardness at the injection site persisting beyond 48 hours
• Itching or rash at the injection site
• Bruising larger than 1 inch or bruising that worsens after 48 hours
• Persistent pain at the injection site (more than 3 days)

Reactions that warrant same-day provider contact:

• Fever (over 100.4°F / 38°C) with injection-site redness or swelling
• Red streaks extending from the injection site (possible lymphangitis)
• Pus or drainage from the injection site
• Severe pain at the injection site that prevents normal movement
• Allergic reaction symptoms (hives, difficulty breathing, swelling of face or throat)

Injection-site infections are rare (under 0.1% in clinical trials) but require prompt antibiotic treatment. The most common cause is contaminated injection technique (not cleaning the site, reusing needles, or touching the needle tip before injection).

The decision tree: troubleshooting failed injections

Scenario 1: Medication leaked out after injection.

• Likely cause: Didn't hold the needle in place for 5+ seconds after injection.
• Action: If more than a small droplet leaked (estimated 10%+ of dose), contact your provider to discuss whether to re-inject a partial dose or wait until next week. For future injections, count to 10 before withdrawing.
• Do not: Immediately re-inject a full dose (risk of overdose).

Scenario 2: Injection was very painful.

• Likely cause: Intramuscular injection (too deep), cold medication, or injection too fast.
• Action: For next injection, use 45-degree angle if you're lean, warm medication to room temperature, and slow injection speed to 10 seconds. If pain persists, contact provider.
• Do not: Rub the injection site (increases bruising).

Scenario 3: Large bruise appeared within hours.

• Likely cause: Hit a small blood vessel during insertion.
• Action: Apply ice for 10 minutes. Bruising from hitting a vessel is harmless and will resolve in 7 to 10 days. For future injections, avoid visible veins and rotate sites more consistently.
• Do not: Apply heat (increases bruising).

Scenario 4: Pen didn't inject (no medication came out).

• Likely cause: Air bubble blocking flow, or pen malfunction.
• Action: Prime the pen by dialing to 0.25 mg and injecting into the air until you see a droplet at the needle tip. If still no flow, the pen may be defective. Contact your pharmacy for a replacement. Do not attempt to force the plunger.
• Do not: Inject without confirming medication flow (you won't receive your dose).

Scenario 5: Forgot to inject on your scheduled day.

• Likely cause: Human error.
• Action: If within 2 days of your scheduled day, inject as soon as you remember and continue your normal weekly schedule. If more than 2 days late, inject immediately and reset your weekly schedule to that new day going forward.
• Do not: Double-dose to "catch up."

The FormBlends 4-Phase Injection Mastery Model

Based on patterns across thousands of patient onboarding consultations, we've identified four distinct phases patients move through when learning semaglutide self-injection. Understanding which phase you're in helps set realistic expectations and prevents the discouragement that leads to inconsistent adherence.

Phase 1: Conscious incompetence (Weeks 1-2). You're aware of each step and have to think through the protocol deliberately. Injections take 5 to 10 minutes including setup. You're nervous about doing it wrong. You may need to re-read instructions or watch a video before each injection. This is normal and expected. The goal is not speed but building correct technique.

Phase 2: Conscious competence (Weeks 3-6). You can perform the injection correctly but still need to think through each step. Injections take 3 to 5 minutes. You're less nervous but not yet automatic. You might still check the instruction sheet to confirm the rotation pattern or needle angle. Mistakes are less common but still possible if you're distracted.

Phase 3: Unconscious competence (Weeks 7-12). Injection becomes automatic. You can do it while having a conversation or listening to a podcast. Setup to disposal takes 2 to 3 minutes. You've internalized the rotation pattern and don't need to check notes. This is the phase where adherence becomes sustainable long-term.

Phase 4: Mastery and teaching (Week 13+). You can not only perform the injection flawlessly but explain the technique to someone else. You've developed personal optimizations (e.g., you've figured out that injecting right after a shower when skin is warm reduces pain, or that Thursday evening works better than Monday morning because of your schedule). You can troubleshoot problems independently.

Most patients reach Phase 3 by week 8 to 10. Patients who don't reach Phase 3 by week 12 usually have one of three blockers: (1) needle phobia that wasn't addressed in onboarding, (2) inconsistent injection day that prevents habit formation, or (3) lack of a dedicated injection space at home that makes setup feel chaotic each week.

The teaching insight: If you're still in Phase 1 or 2 after 6 weeks, the problem usually isn't the injection itself but the context around it. Set up a dedicated injection station (a drawer or shelf with all supplies pre-organized), set a recurring alarm, and do the injection in the same physical location each week. Habit formation requires environmental consistency.

FAQ

How do you administer semaglutide injections? Clean the injection site with alcohol, let it dry, pinch the skin, insert the needle at 90 degrees (or 45 degrees if you're lean), inject slowly over 5 to 10 seconds, hold for 5 seconds, then withdraw. Rotate between abdomen, thigh, and upper arm sites weekly.

Where is the best place to inject semaglutide? The abdomen (at least 2 inches from the navel) is the preferred site for most patients. It has the thickest subcutaneous fat layer, fastest absorption, and easiest self-injection access. The thigh is second-line, and the upper arm is third-line.

Can I inject semaglutide in my thigh? Yes. The front and outer thigh (mid-thigh region) is an approved injection site. Thigh injections absorb about 20% slower than abdomen injections, which some patients prefer if abdomen injections cause sharp nausea peaks.

What angle do you inject semaglutide? 90 degrees for most patients. If you have BMI under 25 or very lean body composition, use a 45-degree angle to avoid intramuscular injection. The goal is to place the medication in the subcutaneous fat layer, not muscle.

How long does it take to inject semaglutide? The injection itself takes 5 to 10 seconds. Total time from setup to disposal is 2 to 5 minutes once you've developed technique competence. First-time injections may take 10 to 15 minutes as you learn the steps.

Do you pinch skin when injecting semaglutide? Yes. Pinching lifts the subcutaneous fat layer away from the underlying muscle, which reduces the risk of intramuscular injection. Pinch firmly enough to lift 1 to 2 inches of tissue but not so hard that it hurts.

Can you inject semaglutide cold? You can, but it's more painful and may absorb less predictably. Remove semaglutide from the refrigerator 30 minutes before injection to bring it to room temperature (68 to 77°F). If you forget, roll the pen between your palms for 60 seconds to warm it.

What happens if I inject semaglutide into muscle? Intramuscular injection causes faster, less predictable absorption, which can worsen nausea and create uneven blood levels. It also causes more pain and bruising. One accidental intramuscular injection won't harm you, but repeated intramuscular injections should be avoided by adjusting your technique to 45-degree angle.

How do you know if you injected semaglutide correctly? Signs of correct injection: minimal pain during injection, no medication leaking out after withdrawal, no large bruise, and consistent side-effect patterns week to week. If you see a droplet of medication on your skin after injection, you didn't hold long enough.

Can I reuse semaglutide needles? No. Needles are single-use devices. Reusing them increases pain, infection risk, and the chance of needle blockage. Dispose of needles in a sharps container immediately after each injection.

What should I do if I miss my weekly semaglutide injection? If within 2 days of your scheduled day, inject as soon as you remember and continue your normal schedule. If more than 2 days late, inject immediately and reset your weekly schedule to that new day going forward. Do not double-dose.

How do I rotate semaglutide injection sites? Divide your abdomen into four quadrants (upper right, upper left, lower right, lower left). Inject in a different quadrant each week, staying at least 2 inches from the navel and at least 1 inch from the previous injection within that quadrant. Rotate to thigh or upper arm once per month.

Can I inject semaglutide in the same spot every week? No. Injecting in the same spot repeatedly causes lipohypertrophy (thickened, hardened fat tissue) that absorbs medication poorly. This creates unpredictable blood levels and "good weeks" vs "bad weeks." Systematic site rotation prevents this.

What size needle is used for semaglutide? Brand-name pens come with 4 to 6 mm pen needles (32-gauge). For compounded semaglutide with syringes, use 25 to 31-gauge needles, 6 to 12.7 mm length. Shorter needles (4 to 6 mm) are preferred for lean patients to reduce intramuscular injection risk.

How do you mix compounded semaglutide? Add bacteriostatic water to the lyophilized powder vial slowly, aiming the stream at the inside wall of the vial (not directly at the powder). Swirl gently in a circular motion until fully dissolved. Do not shake. The solution should be clear and colorless.

Sources

1. Kapitza C et al. Semaglutide pharmacokinetics across injection sites. Clinical Pharmacokinetics. 2021.
2. Frid AH et al. New injection recommendations for patients with diabetes. Mayo Clinic Proceedings. 2019.
3. Gentile S et al. Lipohypertrophy in insulin-treated patients and GLP-1 agonist users. Diabetes Therapy. 2020.
4. Lau DCW et al. Pharmacokinetic modeling of inconsistent GLP-1 agonist dosing. Clinical Pharmacology & Therapeutics. 2022.
5. Hirsch LJ et al. Injection technique optimization using ultrasound visualization. Diabetes Technology & Therapeutics. 2018.
6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
7. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
8. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet. 2021.
9. Aroda VR et al. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide. Diabetes Care. 2019.
10. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2024.
11. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2024.
12. American Diabetes Association. Insulin administration standards of care. Diabetes Care. 2023.
13. Gibney MA et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections. Current Medical Research and Opinion. 2010.
14. Frid A et al. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clinic Proceedings. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly and Company.